Delivery Order SPE2DB22D2103-SPE2DB25FR9WX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,352.44 to AmerisourceBergen Drug Corp for the supply of Contrave ER 8-90 mg tablets (120 count) on September 11, 2025, with completion expected by September 12, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The...
- The Defense Logistics Agency awarded a $1,743.16 firm fixed price delivery order to AmerisourceBergen Drug Corp for Contrave ER 8-90 mg tablets (120 count) on September 10, 2025, with completion scheduled for September 11, 2025. This non-set-aside competitive award was fulfilled at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,563.72 to AmerisourceBergen Drug Corp for the supply of Contrave ER 8-90 mg tablets (120 count), with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,070.95 on July 29, 2025, for the supply of Contrave ER 8-90 mg tablets (120-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 30, 2025. As a delivery order, this award is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $6,406.51 to AmerisourceBergen Drug Corp for Contrave ER 8-90 mg tablets (120 count) on August 1, 2025, with completion targeted for August 4, 2025. This competitively awarded, firm fixed-price delivery order utilizes no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $3,391.13 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Contrave ER 8-90 mg tablets (120-count unit). This is a firm fixed-price, non-set-aside contract with a completion date of July 29, 2025, and performance location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,515.09 delivery order for Contrave ER 8-90 mg tablets (120-count units) on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $18,663.30 to AmerisourceBergen Drug Corp for the supply of Contrave ER 8-90 mg tablets (120-count units) on September 3, 2025, with completion scheduled for September 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $4,829.52 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Contrave ER 8-90 mg tablets (120-count units). This contract represents a firm fixed-price delivery order with no set-aside designation, executed through competitive procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order carries an ultimate completion date...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Contrave ER 8-90 mg tablets (120-count units) valued at $2,449.83 with a completion date of August 1, 2025. This competitive award, issued without set-aside designation, represents a firm fixed-price delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The contract will be performed at the vendor's corporate office...
- SPE2DB22D2103Indefinite Delivery Contract
- SPE2DB22D2103-SPE2DB25FR9WXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,012.78 to AmerisourceBergen Drug Corp for the supply of Contrave ER 8-90 mg tablets (120 count) on September 26, 2025, with completion scheduled for September 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly for military and veteran healthcare systems. The company's portfolio of federal contract awards demonstrates extensive experience delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. Contrave, an FDA-approved prescription weight-management medication, represents one of the specialized pharmaceutical products the company provides through its DLA contract vehicles. The DLA Troop Support Medical contract reflects AmerisourceBergen's capability to meet federal procurement requirements through open competition and to fulfill diverse federal medical supply needs at varying order values, ranging from small transactions to substantial orders exceeding $45,000.